Synchronous Renal and Hepatocellular Carcinomas

1. Garcia JH, Coelho GR, Cavalcante FP, Valenca JT, Brasil IR, Cesar-Borges G, Costa PE, Viana CF, Rocha TD, Vasconcelos JB. Synchronous hepatocellular carcinoma and renal cell carcinoma in a liver transplant recipient: case report // Transplantation, 2007; 84:1713Search in Google Scholar

2. Hayat MJ, Howlader N, Reichman ME, Edwards BK. Cancer statistics, trends, and multiple primary cancer analyses from the Surveillance, Epidemiology, and End Results (SEER) Program // Oncologist, 2007; 12(1):20 – 37Search in Google Scholar

3. Imura S, Shimada M, Utsunomiya T, Morine Y, Ikemoto T, Mori H, Arakawa Y, Kanamoto M, Iwahashi S, Miyake H. Clinicopathological characteristics of patients with non-B non-C hepatocellular carcinoma: a special reference to metabolic syndrome // Hepatogastroenterology, 2014; 61:129 – 135Search in Google Scholar

4. Kilciksiz S, Gokce T, Baloglu A, Calli A, Kaynak C, Kilic B, Eski E, Nalbantoglu G, Yigitbas HA. Characteristics of synchronous- and metachronoustype multiple primary neoplasms: a study of hospital based cancer registry in Turkey // Clin Genitourin Cancer, 2007; 5: 438 – 445Search in Google Scholar

5. Lee YS, Kim JH, Yoon HY, Choe WH, Kwon SY, Lee CH. A synchronous hepatocellular carcinoma and renal cell carcinoma treated with radio-frequency ablation // Clin Mol Hepatol, 2014; 20:306 – 309Search in Google Scholar

6. Lopez ML, Lana A, Diaz S, Folgueras MV, Sanchez L, Comendador MA, Belyakova E, Rodriguez JM, Cueto A. Multiple primary cancer: an increasing health problem. Strategies for prevention in cancer survivors // Eur J Cancer Care (Engl), 2009; 18:598 – 60510.1111/j.1365-2354.2008.00974.x19486126Search in Google Scholar

7. Lu K, Song XL, Han SL, Wang CH, Zhong N, Qi LF. Potential study perspectives on mechanisms and correlations between adiposity and malignancy // Asian Pac J Cancer Prev, 2014; 15:1057 – 1060Search in Google Scholar

8. Rosmorduc O, Chevreau C, Dielenseger P, Ederhy S, Goldwasser F, Grange JD, Mortier L, Neidhardt-Berard ME, Robert C, Scotte F, Seitz JF. Use of sorafenib in patients with hepatocellular or renal carcinoma // Gastroenterol Clin Biol, 2010; 34: 161 – 167Search in Google Scholar

9. Rustagi T, Zarookin EI, Qasba O, Diez LF. Chronic hepatitis C as a risk factor for colorectal adenoma // Int J Colorectal Dis, 2014; 29(1):75 – 80Search in Google Scholar

10. Shetty GS, Bhalla P, Desai SM, Wagle PK, Mehta HS. Synchronous hepatocellular carcinoma with renal cell carcinoma: a case report and review of literature of multiple synchronous primary malignancies // Indian J Surg, 2013; 75 (Suppl 1):S290 – S29210.1007/s12262-012-0684-4369336824426594Search in Google Scholar